Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

The model is the first of its kind to use multiple types of imaging and language-based data to assess a cancer patient's ...

In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases ...

(Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced ...

Antigen-independent single-cell circulating tumor cell detection using deep-learning-assisted biolasers - ...

The CDE of China's NMPA has granted BTD to Innovent Biologics' IBI343 as a monotherapy treatment for CLDN18.2-positive PDAC ...